Nektar TherapeuticsNKTRNASDAQ
Loading
Enterprise value to sales ratio
3Y CAGR
+44.7%/yr
vs +0.3%/yr prior
5Y CAGR
-4.7%/yr
Recent acceleration
Acceleration
+44.4pp
Accelerating
Percentile
P71
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
2 yr
Consecutive growthNormalizing
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 15.34 | +504.9% |
| 2024 | 2.54 | +20.3% |
| 2023 | 2.11 | -58.4% |
| 2022 | 5.06 | -80.1% |
| 2021 | 25.46 | +30.3% |
| 2020 | 19.54 | -45.3% |
| 2019 | 35.68 | +612.9% |
| 2018 | 5.00 | -83.9% |
| 2017 | 31.05 | +170.1% |
| 2016 | 11.49 | - |